chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Swollen eyes, swollen lips, and tongue. Hives formed throughout entire body. Discovered in the early morning hours while she was asleep.
T101, lt arm site of shot, was swollen, red; rash; exp stomach cramping & vomiting; F/U was done 16JUL91; was only showing sx for 1 day; Is finishing meds-Pred & ATB;
Cutaneous Nodule, Dizziness, Asthenia/Fatigue, Secondary transmission  - Information has been received from a female consumer who was exposed to her one year old female niece who was vaccinated with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) (date not reported).  Subsequently, the reporter sexperienced bumps on face and a few scattered throughout the rest of her body.  She also experienced dizziness and lethargy.  The experience of the one year old female is reported in waes# 00111523.  Additional information has been requested.
The patient was given the wrong vaccine. They came in for an influenza vaccine, however they received the RSV vaccine
I have severe pain in my arm and my neck broke out, loosed out; I have severe pain in my arm and my neck broke out, loosed out; I have no or any movement in my arm; I have limited mobility in my arm; They found a fluid sac where the injection was put in that; I have a fluid around where the injection was in my arm; This is a spontaneous report from a contactable consumer reported a 66-year-old male received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13) via an unspecified route of administration on Sep2020 either 17 or 24th at a single dose on his arm for immunization. The patient's medical history was not reported. The patient took 'Fragmin' and he was not sure what he took his wife does all that for him. The reporter stated that he had the shot a month ago and ever since then for the first two weeks, he had severe pain in his arm and his neck broke out, loosed out, now that healed up, his doctor put him on couple of medications (Unspecified Medication) but now he had no or any movement in his arm and now the doctor was going to send him to an orthopedic. He had an ultrasound of the arm and shoulder done and they found a fluid sac where the injection was put in that, now do ever hear anything like that. The patient did not know if they had any solutions to how he can solve this because his doctor put him on antibiotics (unspecified medication) but that did not work. The sac (Intent: fluid sac) on the injection was immobilizing the patient. The patient added he can move his neck and limited mobility in his arm. The consumer stated that he had been taking Gabapentin 300 mg capsules and just started Amoxicillin-Clav 125 mg and the doctor had him on some pain pills but he didn't really take pain pills (Unspecified Medications). The outcome of the events severe pain in his arm and his neck broke out, loosed out was recovered and the outcome of the other events was unknown.  No follow-up attempts are possible, information about batch number cannot be obtained.
Palpitations and accelerated hypertension. Blood pressure and heart rate remained high after an hour of monitoring so was sent to ED in same facility for follow up. Heart rate was 103 and Blood pressure was 157/85 (My normal BP is 110/62).
Chief Complaint: Shortness of breath Additional Medical History:  Patient is a 84-year-old female with a history of COPD as well as CHF on 4 L nasal cannula at home at all times who presents the emergency department via EMS for acute onset of shortness of breath over the evening.  Patient was found to be saturating in the low 80s on first responder arrival.  On EMS arrival they placed her on a nonrebreather and she continues to in the high 80s and was placed on CPAP which improved her saturations to the low 90s.  Patient denies any chest pain.  She does report feeling very tight in her chest and wheezing.  No fevers or chills.  No productive cough.
Pt presented with fever and fatigue, SOB COVID-19 and chest pain and had elevated troponin, D-Dimer 605, NSTEMI (non-ST elevated myocardial infarction), asprin and  IV heparin.  Pt developed acute kidney injury.  Discharged to home.
First day: Left chest pain that reached upper left back (near shoulder), difficulty breathing (chest pain is more when breathing).  2nd day: pain is still there. Can now take half breaths without pain. Pain in full breaths. No more pain in the back Treatment: just Tylenol
is past due for dose two of Shingrix / received dose one in September of 2019; This case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in September 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional detaails were provided as follows: The age at vaccination was not applicable for this report. The health care professional did not provide any patient demographics. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The health care professional did not provide complete address, lot number or expiration date of product. The health care professional did not specify what type of health care professional they were. The health care professional left web form and AE data collected from the submitted web form.
vertigo, light headed, pulse about 80, resp about 16/18, improved after 25 minutes
One week after injection, the injection site began to itch and turned red with some puffiness about the size of a quarter.
Patient felt chills, Vitals were taken, Vitals within normal limits. Patient was in Obsveration for 60 mins, vitals still within normal limits, no chills/hot flashes, tingling sensation in mouth. Patient stated she has "cloudy" feeling. Patient able to tolerate foods and fliuds and able to communicate needs. NP visualize inside patients mouth/cleared. Patient was able to leave the clinc after 60 mins. patient is aware to follow up with MD if symtoms worsen.
Information has been received from a 71-year-old female who on 17-DEC-2007 at 10:00 was vaccinated subcutaneous in the left arm with a dose of ZOSTAVAX.  On 18-DEC-2007 the patient had "redness at site" and "presently increasing area is painful".  "Presently redness and pain increasing".  The patient also reported that she had not expected the redness and tender area to develop.  At the time of the report the patient's status was unknown.  Additional information has been requested. 06/24/2008 This is in follow-up to report(s) previously submitted on 3/26/2008. Additional information has been received from the responsible physician. The physician indicated the patient picked up the dose at the pharmacy with prescription and had a coworker (registered nurse) give it; therefore, details of the injection were not known. However, the physician did indicate the patient recovered from the events. Additional information is not expected.
Patient had a Petit Mal Seizure SP vaccine administration .  Seizure lasted 25 seconds , followed by somnolence.  Patient fully recovered from the seizure.  Her vitals  were taken , BP found to be extremely elevated.   Patient  has an existing hx of seizure , stated  that  she took her BP and seizure medication  this  AM .  Patient refused to go to the ER  for further evaluation .  Patient was informed of all possible outcomes  including stroke and / or death.  Patient signed AMA  and patient states she will call the ambulance from home of she continues to feel ill.  Patient left the clinic after 1 hour.
Product storage error; Administering past the date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administering past the date) and PRODUCT STORAGE ERROR (Product storage error) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administering past the date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Product storage error). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administering past the date) and PRODUCT STORAGE ERROR (Product storage error) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product reported by reporter. No treatment medication reported by reporter. expiration date was 19-Mar-2022.
Exhaustion, slept for four hours.  Woke up feeling exhausted and nauseous.  Couldn?t eat anything for 6+ hours, when I tried to eat instead I threw up until there was nothing in my stomach.  Lots of bathroom urgency through the day and night
The County Health Department was on-site at Senior Living Community for a scheduled FLU Clinic on Wednesday, October 9, 2019. The event started at 10:00 a.m., but  we had been asked to visit the homes of two immobile patients in the community to administer their FLU shots. I received a call from Hospice to report agitation, delusions and anxiety which she noticed today (10/10/2019) from her patient in Hospice care. She said she was aware there may be no connection to the vaccine, but she wanted to report it since she had seen changes in mental status of both of her Hospice patients who had a Flu vaccine at yesterday's off-site Clinic. Hospice said she had given the patient Roxenol to settle him down. When our Nurse was there to administer the vaccine, she did not notice any of the symptoms described by hospice for patient. Nurse said the patient seemed responsive to her questions. His wife signed the Consent for him.
sore throat; nausea; injection site redness; dermatofibroma/hardened area under skin; fatigue; confusion; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 81-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Right on 02Feb2021 11:00 (Batch/Lot Number: EN9265) as dose 1, single, dose 2 via an unspecified route of administration, administered in Arm Right on 23Feb2021 14:00 (Batch/Lot Number: EN6200) as dose 2, single for covid-19 immunisation (age at vaccination 81 year old). Medical history included congenital heart failure, atrial fibrillation, essential tremor, Known Allergies: PCN, Tetracycline, Erythromycin, Rocephin, sulfa, codeine, ms, demerol from an unknown date and unknown if ongoing. Concomitant medication(s) included propranolol hydrochloride (INDERAL); atorvastatin (ATORVASTATIN); apixaban (ELIQUIS); montelukast sodium (SINGULAIR); duloxetine hydrochloride (CYMBALTA) taken for an unspecified indication, start and stop date were not reported. The patient previously took tetracycline and experienced Known Allergies: tetracycline, erythromycin and e Known allergies: Rocephin, rocephin [ceftriaxone] and experienced drug hypersensitivity, codeine and experienced drug hypersensitivity. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On unspecified date, the patient experienced sore throat, nausea, injection site redness, dermatofibroma/hardened area under skin, fatigue, confusion. Adverse event: sore throat, nausea, sore arm with reddened area at injection site (2 inches) with hardened area under skin, fatigue, occasional fogginess. No treatment was received. The outcomr for all events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Pt was administered 3 vaccines on each arm. Pt was feeling well at first. H was not talkative and expressed being  nervous about vaccines. He denies any side effects from vaccines in the past. Pt was reminded to tell father or nurse if he was not feeling well. He nodded and agreement and I proceeded to administer vaccines. Pt was reminded to relax and practice deep breathing during administration of vaccines. Once I finished, pt was asked if he was feeling well, he shook his hand and started to cry. Pt was unable to stand. H reports feeling weak and dizzy. Pt was kept in exam room to monitor symptoms. Pt denies eating this morning. He was given an ice pack to use on back of neck and forehead. Father was with pt during entire time of nurse visit. Pt stayed in clinic for at least 20 minutes to monitor symptoms. Pt was feeling better and was able to walk by himself. He reports feeling a lot better after resting in exam room.
Joint pain throughout entire body lasting 4 weeks, every joint hurt, depression, change in mood, headaches, nausea, and fatigue
Patient was sitting in observation area immediately post vaccine and he suddenly lost consciousness and his head slumped back briefly. Within 3 minutes patient regained consciousness and was very sweaty and anxious. Provided patient cod compress and water and blood sugar boosting snack. Paramedics arrived.
Local induration, 4 cm dia hive at site of injection. Mild generalized itching x 24hrs. Poss focal papule (L) cheek - poss early varicella-like reaction this did not develop a blister. All resolved in 48hrs.
Pt recvd vax 9AM & 950 PC pt exp shaking episode of rt arm; 11AM temp to 104.6 p/episode of shaking of arms & legs followed by;
This spontaneous report was received from a pharmacist concerning a female patient of unknown age. On 13-SEP-2012, the pharmacist was injecting a dose of 0.65 milliliter ZOSTAVAX (lot number unspecified) subcutaneously to a patient in the pharmacy. While injecting, the ZOSTAVAX dripped down her arm. No concomitant medications were reported. Additional information has been requested.
SKIN FEELS SENSITIVE/TINGLING; SKIN FEELS SENSITIVE/TINGLING; FEELS LIGHTHEADED; HEADACHE; FEVER 102 DEGREES; This spontaneous report received from a patient concerned a 19 year old male. The patient's weight was 125 pounds, and height was 67 inches. The patient's concurrent conditions included non smoker, abstains from alcohol, and penicillin allergy, and other pre-existing medical conditions included patient did not have any drug abuse/illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, and batch number: 201A21A expiry: 23-JUN-2021) dose was not reported, administered on 08-APR-2021 09:30 for prophylactic vaccination. No concomitant medications were reported. On 08-APR-2021, the subject experienced skin feels sensitive/tingling. On 08-APR-2021, the subject experienced feels lightheaded. On 08-APR-2021, the subject experienced headache. On 08-APR-2021, the subject experienced fever 102 degrees. On 08-APR-2021, the subject experienced skin feels sensitive/tingling. Laboratory data included: Body temperature (NR: not provided) 102 deg, and COVID-19 virus test negative (NR: not provided) Negative. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache, skin feels sensitive/tingling, feels lightheaded, fever 102 degrees, and skin feels sensitive/tingling. This report was non-serious.
Fully vaccinated person became symptomatic for COVID-19 on 8/22/21 and tested positive on 8/22/21.
This spontaneous report was received from a physician, via company representative, and refers to a patient of unknown age and gender. The physician mentioned that he recently reviewed a manuscript that reported a ZOSTAVAX-related death (dose, lot number, route, date of vaccination and date of the event were not provided). The report would be electronically published (journal unknown). The cause of death was not provided. It was unknown if autopsy was performed. The causality between the suspect drug and the event was not reported. Additional information has been requested.
This case was reported by a consumer via call center representative and described the occurrence of erythema in a 50-year-old male patient who received SHINGRIX for prophylaxis. On 25th January 2019, the patient received the 1st dose of SHINGRIX. In January 2019, less than a week after receiving SHINGRIX, the patient experienced erythema, pain, fever, nausea, weakness, headache and influenza-like symptoms. On an unknown date, the outcome of the erythema, pain, fever, nausea, weakness, headache and influenza-like symptoms were unknown. It was unknown if the reporter considered the erythema, pain, fever, nausea, weakness, headache and influenza-like symptoms to be related to SHINGRIX. Additional details were reported as follows: The caller was reporting adverse event for her husband. The patient received SHINGRIX vaccine on left arm. The patient experienced flu like symptoms, redness, soreness, fever, nausea, weakness and headache. The reporter did not consent to follow up. No further details were provided. This case has been linked with US2019015763 and US2019GSK020713, reported by same reporter.
Death related to Complications of right femur fracture and secondary OSD: COVID-19 infection
Aprox 12:30pm, teh day following vaccination, patient was at school with friends and just started to stare off and not answer her friends when they addressed her. The kids said this last a  few minutes and then patient answered and someone walked her to the nurse.  Sounds like a focal aware seizure that she has experienced 2x during summer when her medication needed to be increased. She has not had one since July, 2021.
Pronounced blood vessels in both hands.  Blue hands due to vasculitis that lasted for 10 minutes.
24 hours post injection Pt stated that the injection site became itchy, swollen and red. These symptoms lasted for 5 days.
Pt recvd vax & devel pain @ inject site which lasted about 7 to 8 mins a/resolving; pt also c/o of a sore & heavy arm all day;
2nd Shingles shot. When I woke up the next morning, I felt like I had come down with the Flu. Every joint ached, 8 on a 1-10 scale. Even laying still in bed was painful. I bathed in 100+ degree tub and felt a little better. I also took ADVIL, Tramadol 50mg and Chlorzoxazone 500mg. Went back to bed for a couple of hours and pain level down to a 3.
Headache; Fatigue; Muscle/ joint pain; Muscle/ joint pain; This is a spontaneous report from a contactable physician (patient). A 40-year-old female patient (no pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: Eh9899) Intramuscularly on 26Dec2020 10:30 AM (Anatomical Location: Arm Left) at single dose (first dose) for COVID-19 immunization. Medical history and concomitant medications were reported none. Patient did not have any allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient experienced Headache, Fatigue, Muscle/ joint pain on 26Dec2020 12:30 PM. Patient did not receive any treatment. The outcome of the events was recovered in unknown date. This case was assessed non-serious by reporter. The events did not result in death, Life threatening, Caused/prolonged hospitalization, Disabling/Incapacitating, Congenital anomaly/birth defect.
Late entry for 1/28/21 at 12:00 noon. Received info. reg possible reaction to Covid 19 vaccine 2nd dose. Triaged pt. Pt. sitting in office. Per pt. stated feels warm and face is hot. Per pt. bil hand are cold and clammy. Pt's faced is flushed and slight swelling noted. Per pt. feels throat is swollen an slightly tight. Pt. is able to speak well and is able to swallow. V/S B/P 161/100, Pulse-84 and Resp. 20. PO Benadryl 25mg given. Post 20min at 12:20pm per pt. felt a little better. B/P at this time 155/96. Con't with face flushed and hands feel cold, no longer clammy. BS checked, results 97. clinic manager informed of incident. Post 45min at 1:05pm, pt stated felt much better, does not feel throat closing or discomfort. Pt. remained alert and talkative. Pt. instructed on OTC Benadryl to always have at home, go to see PCP and of ER precautions. Pt's brother and mother on their way to pick her up and take her home. Pt. left  and was  alert and  talkative.
DIZZINESS (HEAD RUSH); BRAIN FOGGINESS; FELT HOT; FEVER; PULSING IN THE PLACE OF THE SHOT; This spontaneous report received from a consumer. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1808982, expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 10:30 for prophylactic vaccination. No concomitant medications were reported. On 08-APR-2021, Laboratory data included: Body temperature (NR: not provided) 98.9 F. On 08-APR-2021, treatment medications included: ibuprofen. On 08-APR-2021 18:00, the subject experienced dizziness (head rush). On 08-APR-2021 18:00, the subject experienced brain fogginess. On 08-APR-2021 18:00, the subject experienced felt hot. On 08-APR-2021 18:00, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fever, and had not recovered from dizziness (head rush), pulsing in the place of the shot, brain fogginess, and felt hot. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure as case assessed as non-serious.
Patient received 2nd dose of Janssen Covid 19 Vaccine instead of receiving first dose of Moderna Covid 19 Vaccine.
Patient received Shingrix on 10/14/21 that expired on 10/1/21. I have not heard from the patient regarding any adverse reactions.
Breathing difficulties sent to ER. Does have asthma, given steroid and nebulizer in ER then released.
Patient received the both immunizations on 9/23. She came back to the pharmacy on 9/24. Her arm was swollen some, very red and hot to the touch. She also reported a good deal of pain.
Face, neck, arm, elbow, back, and knees became swollen. Went to the dr. and referred her to a hematologist due to her white blood cells count was very high.
Chills, fever, headache, body aches, underarm on L side very swollen and sore, symptoms lasted 48 hours with underarm swelling for 72 hours after injection.
Patient fainted after receiving H1N1 and regular Influenza injections on 11/17/09. On 11/18/09-Mom took her to ER for itching all over body, felt like throat swelling, itching in mouth, coughing that caused numbness and tingling in hands, muscle cramps arms and legs.
Immediate facial twitching when first vaccine, covid, went into arm. Lasted 3 days at regular frequency, then intermittent for several days. Still feeling some twitching.
Case number PHHY2013US117554 is an initial spontaneous report from a health care professional via Vaccine Adverse Event Reporting System (VAERS reference number: 494580) website on 15 Oct 2013. This case refers to a 34-year-old female patient. Her medical history included attention deficit hyperactivity disorder (ADHD) and allergy to sulfa drugs. Her concomitant medications included LOESTRIN FE and ADDERALL. She was vaccinated with Influenza vaccine (unknown manufacturer, batch number: not reported, so conservatively coded as Seasonal Influenza vaccine INN) on an unknown date. On an unknown date after vaccination the patient developed chills and aches. The outcome, seriousness and causality assessment of the events was not reported.